Literature DB >> 16183118

Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.

Catherine A Tucker1, Gwyn Bebb, Richard J Klasa, Mukesh Chhanabhai, Valia Lestou, Douglas E Horsman, Randy D Gascoyne, Adrian Wiestner, Dana Masin, Marcel Bally, Michael E Williams.   

Abstract

The objectives of this study were foremost to further characterize pre-existing cell lines containing the t(11;14)(q13;q32) translocation. This translocation along with cyclin D1 overexpression is characteristic of Mantle Cell Lymphoma (MCL), an aggressive B cell neoplasm. Considerable variation in the abundance of cyclin D1 expression was observed. mRNA levels were examined by RT-PCR as differences in cyclin D1 mRNA abundance have been shown to synergize with INK4A/Arf deletions to dictate proliferation rate and survival in MCL patient samples. In this study, the cell lines, Z-138 and HBL-2, which exhibited the fastest growth rates and the shortest survival times in Rag2-M mice, had high expression of either one or both cyclin D1 mRNA isoforms and had negligible expression of p16. On the other hand, NCEB-1 and JVM-2 had low expression of both mRNA isoforms, retained p16 expression, and had slower growth rates and exhibited longer survival times in Rag2-M mice. Furthermore, JVM-2, which was found to have the lowest expression of cyclin D1, was the only cell line that expressed cyclin D2. The results of the characterization of Z-138, HBL-2, NCEB-1 and JVM-2 reveal that this group of cell lines represents both classic and variant features of MCL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183118     DOI: 10.1016/j.leukres.2005.08.016

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

1.  The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.

Authors:  M Kim; C T Williamson; J Prudhomme; D G Bebb; K Riabowol; P W K Lee; S P Lees-Miller; Y Mori; M M Rahman; G McFadden; R N Johnston
Journal:  Oncogene       Date:  2010-05-17       Impact factor: 9.867

2.  Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo.

Authors:  Paolo Conrotto; Ulrika Andréasson; Venera Kuci; Carl A K Borrebaeck; Sara Ek
Journal:  Mol Oncol       Date:  2011-08-22       Impact factor: 6.603

3.  Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma.

Authors:  Afak Rasheed Salman Zaidi; Sadie Dresman; Charlotte Burt; Simon Rule; Lynn McCallum
Journal:  J Cell Commun Signal       Date:  2018-11-21       Impact factor: 5.782

4.  ATM deficiency sensitizes mantle cell lymphoma cells to poly(ADP-ribose) polymerase-1 inhibitors.

Authors:  Chris T Williamson; Huong Muzik; Ali G Turhan; Alberto Zamò; Mark J O'Connor; D Gwyn Bebb; Susan P Lees-Miller
Journal:  Mol Cancer Ther       Date:  2010-02-02       Impact factor: 6.261

5.  Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma.

Authors:  Michael A Dengler; Charis E Teh; Rachel Thijssen; Lahiru Gangoda; Ping Lan; Marco J Herold; Daniel H Gray; Gemma L Kelly; Andrew W Roberts; Jerry M Adams
Journal:  Oncogene       Date:  2019-11-26       Impact factor: 9.867

6.  Cancer Tissue Engineering: A Novel 3D Polystyrene Scaffold for In Vitro Isolation and Amplification of Lymphoma Cancer Cells from Heterogeneous Cell Mixtures.

Authors:  Carlos E Caicedo-Carvajal; Qing Liu; Yvonne Remache; Andre Goy; K Stephen Suh
Journal:  J Tissue Eng       Date:  2011-09-05       Impact factor: 7.813

7.  Replication-induced DNA damage after PARP inhibition causes G2 delay, and cell line-dependent apoptosis, necrosis and multinucleation.

Authors:  Idun Dale Rein; Kirsti Solberg Landsverk; Francesca Micci; Sebastian Patzke; Trond Stokke
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

8.  Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1.

Authors:  Kazumasa Sekihara; Kaori Saitoh; Lina Han; Stefan Ciurea; Shinichi Yamamoto; Mika Kikkawa; Saiko Kazuno; Hikari Taka; Naoko Kaga; Hajime Arai; Takashi Miida; Michael Andreeff; Marina Konopleva; Yoko Tabe
Journal:  Oncotarget       Date:  2017-05-23

9.  Mitochondrial hypoxic stress induces widespread RNA editing by APOBEC3G in natural killer cells.

Authors:  Shraddha Sharma; Jianmin Wang; Emad Alqassim; Scott Portwood; Eduardo Cortes Gomez; Orla Maguire; Per H Basse; Eunice S Wang; Brahm H Segal; Bora E Baysal
Journal:  Genome Biol       Date:  2019-02-21       Impact factor: 13.583

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.